Back to announcement
20231023_BMHS_Laporan Informasi dan Fakta Material_31470824_lamp1.pdf
Other Text extracted BMHSSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.930
(@ bmhs
since 1973
No. :515-K/PD/BMHS/X/2023
Lampiran/Attachment : -
Perihal/In Reference
Jakarta, October 25 2023
: Informasi Rencana Periode Pelaksanaan Tahap I Window Exercise II Tahun
2023 Program Management and Employee Stock Option Program (MESOP) PT
Bundamedik Tbk/ Information on Planned Implementation Period of Phase I
Window Exercise II of 2023 Program Management and Employee Stock Option
Program (MESOP) of PT Bundamedik Tbk
Kepada Yth./To:
1. Otoritas Jasa Keuangan ("OJK")/Financial Services Authority ("OJK")
Gedung Sumitro Djojohadikusumo / Sumitro Djojohadikusumo Building
Jl. Lapangan Banteng Timur No. 2-4 Jakarta - 10710
Attn./ U.p.: Kepala Eksekutif Pengawas Pasar Modal/Executive Head of Capital Market Supervisory
2. PT Bursa Efek Indonesia ("BEI")/Indonesia Stock Exchange ("IDX")
Gedung Bursa Efek Indonesia Tower 1, Lantai 4 Jend. Sudirman Kav. 52-53 Jakarta -12190
Attn./ U.p.: Direktur Penilaian Perusahaan/Director of Corporate Valuation
Dengan hormat,
Merujuk kepada Pasal 43A Peraturan Otoritas Jasa
Keuangan No. 32/POJK.04/2015 — tentang
Penambahan Modal Perusahaan Terbuka Dengan
Memberikan Hak Memesan Efek Terlebih Dahulu
(sebagaimana diubah dengan Peraturan Otoritas
Jasa Keuangan No. 14/POJK.04/2019) dan Surat
Edaran PT Bursa Efek Indonesia Nomor SE-
00002/BEI/03- 2020 tanggal 2 Maret 2020 perihal
Tata Cara Pelaksanaan Program Kepemilikan
Saham, bersama ini kami sampaikan keterbukaan
informasi sehubungan dengan pelaksanaan
Program Kepemilikan Saham Perseroan sebagai
berikut:
Dear Sirs,
Referring to Article 43A of Financial Services
Authority Regulation No. 32/POJK.04/2015
concerning Capital Increase for Public Companies
by Providing Pre-emptive Rights (as amended by
Financial Services Authority Regulation No.
14/POJK.04/2019) and PT Bursa Efek Indonesia
Circular Letter Number SE-00002/BEI /03- 2020
dated March 2”4, 2020 regarding the Procedures
for Implementing the Share Ownership Program,
we hereby submit information disclosure regarding
the implementation of the Company's Share
Ownership Program as follows:
Sebelumnya/ Pre-Set Execution Price
No. Keterangan/Description | Penjelasan/Explanation
1. Periode Pelaksanaan/Window Exercise 130 (tiga puluh) hari bursa terhitung sejak
| tanggal 1 November 2023 sampai dengan
| tanggal 12 Desember 2023/30 (thirty) trading
days from November 1"', 2023 to December 12,
2023. |
2. Harga Pelaksanaan yang Telah Ditetapkan
Rp. 863 per lembar/ IDR 863 per shares |
3. Jumlah Hak Opsi yang Dikonversi
Period
Untuk Periode Pelaksanaan Ini/ Number of
Option Rights Converted For This Execution
Jumlah Hak Opsi yang Dikonversi untuk Periode |
Pelaksanaan sebanyak-banyaknya 22.500.000
saham dan Hak Opsi yang belum Dikonversi
pada Periode Pelaksanaan ini dapat dilakukan
PT Bundamedik Tbk
Jl. Teuku Cik Ditiro No. 28
Menteng-Jakarta Pusat 10350, Indonesia
Page 2 OCR 0.919
(@ bmhs since 1973 | pada periode pelaksanaan berikutnya/ The maximum number of Converted Option Rights for the Implementation Period is 22,500,000 | Shares and the Option Rights that have not been converted in this Implementation Period can be | exercised in the next implementation period. Demikian surat ini kami sampaikan. Atas perhatian Hereby We convey this letter. Thank you for your dan kerjasamanya, kami ucapkan terima kasih. attention and cooperation. Hormat kami/Regards, PT Bundamedik Tbk P President Director PT Bundamedik Tbk Jl. Teuku Cik Ditiro No. 28 Menteng-Jakarta Pusat 10350, Indonesia 11462 21 3192 3344 & 462 2131905915 & www.bmhs.co.id om Embr rougho fe
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.